Hiroshi Tazawa

10.1k total citations · 1 hit paper
332 papers, 7.8k citations indexed

About

Hiroshi Tazawa is a scholar working on Genetics, Biotechnology and Animal Science and Zoology. According to data from OpenAlex, Hiroshi Tazawa has authored 332 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Genetics, 80 papers in Biotechnology and 75 papers in Animal Science and Zoology. Recurrent topics in Hiroshi Tazawa's work include Cancer Research and Treatments (80 papers), Animal Nutrition and Physiology (74 papers) and Virus-based gene therapy research (70 papers). Hiroshi Tazawa is often cited by papers focused on Cancer Research and Treatments (80 papers), Animal Nutrition and Physiology (74 papers) and Virus-based gene therapy research (70 papers). Hiroshi Tazawa collaborates with scholars based in Japan, United States and Germany. Hiroshi Tazawa's co-authors include Toshiyoshi Fujiwara, Shunsuke Kagawa, Hitoshi Nakagama, Naoto Tsuchiya, Masashi Izumiya, Warren W. Burggren, G. C. Whittow, Shinji Kuroda, James T. Pearson and Johannes Piiper and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Hiroshi Tazawa

322 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

2007 773 citations Hiroshi Tazawa et al. profile →

Peers

Countries citing papers authored by Hiroshi Tazawa

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Tazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Tazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Tazawa more than expected).

Fields of papers citing papers by Hiroshi Tazawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Tazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Tazawa. The network helps show where Hiroshi Tazawa may publish in the future.

Co-authorship network of co-authors of Hiroshi Tazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Tazawa. A scholar is included among the top collaborators of Hiroshi Tazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Tazawa. Hiroshi Tazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts Using a Humanized Anti-Fibroblast Activation Protein Antibody 2024 ·Molecular Cancer Therapeutics ·Teruki Kobayashi, Kazuhiro Noma, (unknown), Takuya Kato, (unknown), Toshiaki Ohara, (unknown), Kento Kawasaki, (unknown), Satoshi Komoto, Hajime Kashima, Satoru Kikuchi, Hiroshi Tazawa, Yasuhiro Shirakawa, Peter L. Choyke, Hisataka Kobayashi, Toshiyoshi Fujiwara	7
2	ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer 2023 ·Scientific Reports ·(unknown), Kunitoshi Shigeyasu, Yuzo Umeda, Shuya Yano, Sho Takeda, Kazuhiro Yoshida, Tomokazu Fuji, Ryuichi Yoshida, (unknown), (unknown), Toshiaki Takahashi, Yoshitaka Kondo, Hiroyuki Kishimoto, Yoshiko Mori, Fuminori Teraishi, Hideki Yamamoto, Hiroyuki Michiue, Keiichiro Nakamura, Hiroshi Tazawa, Toshiyoshi Fujiwara	11
3	Causes and Clinical Outcomes of Patellar Post Impingement 2022 ·Arthroplasty Today ·(unknown), Hidetomo Saito, Hiroaki Kijima, Noriyuki Ishikawa, Yuji Hatakeyama, Hiroshi Tazawa, Naohisa Miyakoshi	1
4	CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment 2021 ·Molecular Cancer Therapeutics ·Tomohiro Fujiwara, Mohamed A. Yakoub, Andrew Chandler, Alexander B. Christ, Guangli Yang, Ouathek Ouerfelli, Vinagolu K. Rajasekhar, Aki Yoshida, Hiroya Kondo, Toshiaki Hata, Hiroshi Tazawa, Yildirim Dogan, Malcolm A.S. Moore, Toshiyoshi Fujiwara, Toshifumi Ozaki, (unknown), John H. Healey	157
5	Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression 2021 ·Cancer Chemotherapy and Pharmacology ·(unknown), Hiroshi Tazawa, Joe Hasei, Yasuaki Yamakawa, (unknown), (unknown), Yusuke Mochizuki, Hiroya Kondo, (unknown), Tomohiro Fujiwara, Aki Yoshida, Toshiyuki Kunisada, Koji Ueda, Yasuo Urata, Shunsuke Kagawa, Toshifumi Ozaki, Toshiyoshi Fujiwara	13
6	Cancer-Associated Fibroblasts Affect Intratumoral CD8+ and FoxP3+ T Cells Via IL6 in the Tumor Microenvironment 2018 ·Clinical Cancer Research ·Takuya Kato, Kazuhiro Noma, Toshiaki Ohara, Hajime Kashima, Yuki Katsura, Hiroaki Sato, Satoshi Komoto, Ryoichi Katsube, Takayuki Ninomiya, Hiroshi Tazawa, Yasuhiro Shirakawa, Toshiyoshi Fujiwara	276
7	Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer 2018 ·Cancer Letters ·Sho Takeda, Kunitoshi Shigeyasu, Yoshinaga Okugawa, Kazuhiro Yoshida, Yoshiko Mori, Shuya Yano, Kazuhiro Noma, Yuzo Umeda, Yoshitaka Kondo, Hiroyuki Kishimoto, Fuminori Teraishi, Takeshi Nagasaka, Hiroshi Tazawa, Shunsuke Kagawa, Toshiyoshi Fujiwara, Ajay Goel	48
8	The usefulness of planning using a preoperative lateral leg image to determine accurate posterior tibial slope in total knee arthroplasty 2018 ·Journal of Orthopaedics ·(unknown), Hidetomo Saito, Hiroaki Kijima, Kimio Saito, Hiroshi Tazawa, Noriyuki Ishikawa, Naohisa Miyakoshi, Yoichi Shimada	4
9	[Novel Therapeutic Strategy for Human Epidermal Growth Factor Receptor 2-Positive Gastric Cancer]. 2017 ·PubMed ·Nobuhiko Kanaya, Shinji Kuroda, Tetsushi Kubota, (unknown), Satoru Kikuchi, Masahiko Nishizaki, Hiroshi Tazawa, Shunsuke Kagawa, Toshiyoshi Fujiwara	3
10	Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer 2015 ·Molecular Cancer Therapeutics ·Kiyoto Takehara, Hiroshi Tazawa, (unknown), Yuuri Hashimoto, Satoru Kikuchi, Shinji Kuroda, Hiroyuki Kishimoto, Yasuhiro Shirakawa, Nobuhiro Narii, Hiroyuki Mizuguchi, Yasuo Urata, Shunsuke Kagawa, Toshiyoshi Fujiwara	18
11	[Therapeutic Potential of Targeting Cancer-Associated Fibroblasts in Esophageal Cancer]. 2015 ·PubMed ·Kazuhiro Noma, Hajime Kashima, Takayuki Ninomiya, Ryoichi Katsube, Shinichiro Watanabe, Toshiaki Ohara, Hiroshi Tazawa, Shunsuke Kagawa, Yasuhiro Shirakawa, Toshiyoshi Fujiwara	1
12	MicroRNA as a molecular target for gastrointestinal cancers 2015 ·Hiroshi Tazawa, Takeshi Nagasaka, Shunsuke Kagawa, Toshiyoshi Fujiwara	8
13	Fluorescence virus-guided capturing system of human colorectal circulating tumour cells for non-invasive companion diagnostics 2014 ·Gut ·Kunitoshi Shigeyasu, Hiroshi Tazawa, Yuuri Hashimoto, Yoshiko Mori, Masahiko Nishizaki, Hiroyuki Kishimoto, Takeshi Nagasaka, Shinji Kuroda, Yasuo Urata, Ajay Goel, Shunsuke Kagawa, Toshiyoshi Fujiwara	22
14	Acute regulation of hematocrit and acid–base balance in chicken embryos in response to severe intrinsic hypercapnic hypoxia 2014 ·Respiratory Physiology & Neurobiology ·Sarah J. Andrewartha, Hiroshi Tazawa, Warren W. Burggren	15
15	Dual Programmed Cell Death Pathways Induced by p53 Transactivation Overcome Resistance to Oncolytic Adenovirus in Human Osteosarcoma Cells 2013 ·Molecular Cancer Therapeutics ·Joe Hasei, Tsuyoshi Sasaki, Hiroshi Tazawa, (unknown), Yasuaki Yamakawa, Toshiyuki Kunisada, Aki Yoshida, Yuuri Hashimoto, (unknown), Futoshi Uno, Shunsuke Kagawa, Yasuo Urata, Toshifumi Ozaki, Toshiyoshi Fujiwara	53
16	A Genetically Engineered Oncolytic Adenovirus Decoys and Lethally Traps Quiescent Cancer Stem–like Cells in S/G2/M Phases 2013 ·Clinical Cancer Research ·Shuya Yano, Hiroshi Tazawa, Yuuri Hashimoto, Yasuhiro Shirakawa, Shinji Kuroda, Masahiko Nishizaki, Hiroyuki Kishimoto, Futoshi Uno, Takeshi Nagasaka, Yasuo Urata, Shunsuke Kagawa, Robert M. Hoffman, Toshiyoshi Fujiwara	64
17	Preclinical Evaluation of Telomerase-Specific Oncolytic Virotherapy for Human Bone and Soft Tissue Sarcomas 2011 ·Clinical Cancer Research ·Tsuyoshi Sasaki, Hiroshi Tazawa, Joe Hasei, Toshiyuki Kunisada, Aki Yoshida, Yuuri Hashimoto, Shuya Yano, (unknown), Futoshi Uno, Shunsuke Kagawa, Yuki Morimoto, Yasuo Urata, Toshifumi Ozaki, Toshiyoshi Fujiwara	43
18	Telomerase-Dependent Oncolytic Adenovirus Sensitizes Human Cancer Cells to Ionizing Radiation via Inhibition of DNA Repair Machinery 2010 ·Cancer Research ·Shinji Kuroda, Toshiya Fujiwara, Yasuhiro Shirakawa, (unknown), Shuya Yano, Futoshi Uno, Hiroshi Tazawa, Yuuri Hashimoto, Yuichi Watanabe, Kazuhiro Noma, Yasuo Urata, Shunsuke Kagawa, Toshiyoshi Fujiwara	61
19	Electrochemical Migration in Three Layer TAB Tape with Tin-plated Lead 1995 ·Koji Shibasaki, (unknown), Hiroshi Tazawa, (unknown), Toshio Sudô, (unknown), (unknown)	1
20	[Histopathology of corneal plaque in vernal keratoconjunctivitis]. 1993 ·PubMed ·(unknown), Takahiko Fukuchi, Hiroshi Tazawa, (unknown), Shoichi Sawaguchi, K Iwata	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact